TrialThe Journal of infectious diseases2014

IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin.

Eric G Meissner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.